Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Type 2 Diabetes Therapeutics Market Share by Type (2020-2026) 1.5.2 DPP-4 Inhibitors 1.5.3 Biguanides 1.5.4 Insulins 1.5.5 SGLT-2 Inhibitors 1.5.6 α-Glucosidase Inhibitors 1.5.7 Other 1.6 Market by Application 1.6.1 Global Type 2 Diabetes Therapeutics Market Share by Application (2020-2026) 1.6.2 Children 1.6.3 Middle-Aged Person 1.6.4 Aged 1.7 Type 2 Diabetes Therapeutics Industry Development Trends under COVID-19 Outbreak 1.7.1 Region COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Type 2 Diabetes Therapeutics Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 3 Value Chain of Type 2 Diabetes Therapeutics Market 3.1 Value Chain Status 3.2 Type 2 Diabetes Therapeutics Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Type 2 Diabetes Therapeutics 3.2.3 Labor Cost of Type 2 Diabetes Therapeutics 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 4 Players Profiles 4.1 Novo Nordisk 4.1.1 Novo Nordisk Basic Information 4.1.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.1.3 Novo Nordisk Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.1.4 Novo Nordisk Business Overview 4.2 Bristol-Myers Squibb 4.2.1 Bristol-Myers Squibb Basic Information 4.2.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.2.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.2.4 Bristol-Myers Squibb Business Overview 4.3 AstraZeneca 4.3.1 AstraZeneca Basic Information 4.3.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.3.3 AstraZeneca Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.3.4 AstraZeneca Business Overview 4.4 Eli Lilly 4.4.1 Eli Lilly Basic Information 4.4.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.4.3 Eli Lilly Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.4.4 Eli Lilly Business Overview 4.5 Boehringer Ingelheim 4.5.1 Boehringer Ingelheim Basic Information 4.5.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.5.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.5.4 Boehringer Ingelheim Business Overview 4.6 Sanofi 4.6.1 Sanofi Basic Information 4.6.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.6.3 Sanofi Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.6.4 Sanofi Business Overview 4.7 Novartis 4.7.1 Novartis Basic Information 4.7.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.7.3 Novartis Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.7.4 Novartis Business Overview 4.8 Merck 4.8.1 Merck Basic Information 4.8.2 Type 2 Diabetes Therapeutics Product Profiles, Application and Specification 4.8.3 Merck Type 2 Diabetes Therapeutics Market Performance (2015-2020) 4.8.4 Merck Business Overview 5 Global Type 2 Diabetes Therapeutics Market Analysis by Regions 5.1 Global Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Regions 5.1.1 Global Type 2 Diabetes Therapeutics Sales by Regions (2015-2020) 5.1.2 Global Type 2 Diabetes Therapeutics Revenue by Regions (2015-2020) 5.2 North America Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 5.3 Europe Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 5.6 South America Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 6 North America Type 2 Diabetes Therapeutics Market Analysis by Countries 6.1 North America Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Countries 6.1.1 North America Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) 6.1.2 North America Type 2 Diabetes Therapeutics Revenue by Countries (2015-2020) 6.2 United States Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 6.3 Canada Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 6.4 Mexico Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7 Europe Type 2 Diabetes Therapeutics Market Analysis by Countries 7.1 Europe Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Countries 7.1.1 Europe Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) 7.1.2 Europe Type 2 Diabetes Therapeutics Revenue by Countries (2015-2020) 7.2 Germany Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7.3 UK Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7.4 France Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7.5 Italy Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7.6 Spain Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 7.7 Russia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8 Asia-Pacific Type 2 Diabetes Therapeutics Market Analysis by Countries 8.1 Asia-Pacific Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Type 2 Diabetes Therapeutics Revenue by Countries (2015-2020) 8.2 China Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8.3 Japan Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8.4 South Korea Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8.5 Australia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8.6 India Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 8.7 Southeast Asia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 9 Middle East and Africa Type 2 Diabetes Therapeutics Market Analysis by Countries 9.1 Middle East and Africa Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Type 2 Diabetes Therapeutics Revenue by Countries (2015-2020) 9.2 Saudi Arabia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 9.3 UAE Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 9.4 Egypt Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 9.5 Nigeria Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 9.6 South Africa Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 10 South America Type 2 Diabetes Therapeutics Market Analysis by Countries 10.1 South America Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Countries 10.1.1 South America Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) 10.1.2 South America Type 2 Diabetes Therapeutics Revenue by Countries (2015-2020) 10.2 Brazil Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 10.3 Argentina Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 10.4 Columbia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 10.5 Chile Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) 11 Global Type 2 Diabetes Therapeutics Market Segment by Types 11.1 Global Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Type 2 Diabetes Therapeutics Sales and Market Share by Types (2015-2020) 11.1.2 Global Type 2 Diabetes Therapeutics Revenue and Market Share by Types (2015-2020) 11.2 DPP-4 Inhibitors Sales and Price (2015-2020) 11.3 Biguanides Sales and Price (2015-2020) 11.4 Insulins Sales and Price (2015-2020) 11.5 SGLT-2 Inhibitors Sales and Price (2015-2020) 11.6 α-Glucosidase Inhibitors Sales and Price (2015-2020) 11.7 Other Sales and Price (2015-2020) 12 Global Type 2 Diabetes Therapeutics Market Segment by Applications 12.1 Global Type 2 Diabetes Therapeutics Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Type 2 Diabetes Therapeutics Sales and Market Share by Applications (2015-2020) 12.1.2 Global Type 2 Diabetes Therapeutics Revenue and Market Share by Applications (2015-2020) 12.2 Children Sales, Revenue and Growth Rate (2015-2020) 12.3 Middle-Aged Person Sales, Revenue and Growth Rate (2015-2020) 12.4 Aged Sales, Revenue and Growth Rate (2015-2020) 13 Type 2 Diabetes Therapeutics Market Forecast by Regions (2020-2026) 13.1 Global Type 2 Diabetes Therapeutics Sales, Revenue and Growth Rate (2020-2026) 13.2 Type 2 Diabetes Therapeutics Market Forecast by Regions (2020-2026) 13.2.1 North America Type 2 Diabetes Therapeutics Market Forecast (2020-2026) 13.2.2 Europe Type 2 Diabetes Therapeutics Market Forecast (2020-2026) 13.2.3 Asia-Pacific Type 2 Diabetes Therapeutics Market Forecast (2020-2026) 13.2.4 Middle East and Africa Type 2 Diabetes Therapeutics Market Forecast (2020-2026) 13.2.5 South America Type 2 Diabetes Therapeutics Market Forecast (2020-2026) 13.3 Type 2 Diabetes Therapeutics Market Forecast by Types (2020-2026) 13.4 Type 2 Diabetes Therapeutics Market Forecast by Applications (2020-2026) 14 Appendix 14.1 Methodology 14.2 Research Data Source

List of Tables and Figures Table Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (2020-2026) Figure Global Type 2 Diabetes Therapeutics Market Share by Type in 2019 & 2026 Figure DPP-4 Inhibitors Features Figure Biguanides Features Figure Insulins Features Figure SGLT-2 Inhibitors Features Figure α-Glucosidase Inhibitors Features Figure Other Features Table Global Type 2 Diabetes Therapeutics Market Size Growth by Application (2020-2026) Figure Global Type 2 Diabetes Therapeutics Market Share by Application in 2019 & 2026 Figure Children Description Figure Middle-Aged Person Description Figure Aged Description Table SWOT Analysis Figure Porter's Five Forces Analysis Figure Global Type 2 Diabetes Therapeutics Market Size and Growth Rate 2015-2026 Table Industry News Table Industry Policies Figure Value Chain Status of Type 2 Diabetes Therapeutics Figure Production Process of Type 2 Diabetes Therapeutics Figure Manufacturing Cost Structure of Type 2 Diabetes Therapeutics Figure Major Company Analysis (by Business Distribution Base, by Product Type) Table Downstream Major Customer Analysis (by Region) Table Novo Nordisk Profile Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020 Table Bristol-Myers Squibb Profile Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2015-2020 Table AstraZeneca Profile Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020 Table Eli Lilly Profile Table Eli Lilly Production, Value, Price, Gross Margin 2015-2020 Table Boehringer Ingelheim Profile Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020 Table Sanofi Profile Table Sanofi Production, Value, Price, Gross Margin 2015-2020 Table Novartis Profile Table Novartis Production, Value, Price, Gross Margin 2015-2020 Table Merck Profile Table Merck Production, Value, Price, Gross Margin 2015-2020 Figure Global Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Global Type 2 Diabetes Therapeutics Revenue ($) and Growth (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales by Regions (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales Market Share by Regions (2015-2020) Table Global Type 2 Diabetes Therapeutics Revenue ($) by Regions (2015-2020) Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Regions (2015-2020) Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Regions in 2015 Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Regions in 2019 Figure North America Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Europe Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Asia-Pacific Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Middle East and Africa Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure South America Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure North America Type 2 Diabetes Therapeutics Revenue ($) and Growth (2015-2020) Table North America Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) Table North America Type 2 Diabetes Therapeutics Sales Market Share by Countries (2015-2020) Figure North America Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2015 Figure North America Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2019 Table North America Type 2 Diabetes Therapeutics Revenue ($) by Countries (2015-2020) Table North America Type 2 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020) Figure North America Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2015 Figure North America Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2019 Figure United States Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Canada Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Mexico Type 2 Diabetes Therapeutics Sales and Growth (2015-2020) Figure Europe Type 2 Diabetes Therapeutics Revenue ($) Growth (2015-2020) Table Europe Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) Table Europe Type 2 Diabetes Therapeutics Sales Market Share by Countries (2015-2020) Figure Europe Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2015 Figure Europe Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2019 Table Europe Type 2 Diabetes Therapeutics Revenue ($) by Countries (2015-2020) Table Europe Type 2 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020) Figure Europe Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2015 Figure Europe Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2019 Figure Germany Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure UK Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure France Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Italy Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Spain Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Russia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Asia-Pacific Type 2 Diabetes Therapeutics Revenue ($) and Growth (2015-2020) Table Asia-Pacific Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) Table Asia-Pacific Type 2 Diabetes Therapeutics Sales Market Share by Countries (2015-2020) Figure Asia-Pacific Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2015 Figure Asia-Pacific Type 2 Diabetes Therapeutics Sales Market Share by Countries in 2019 Table Asia-Pacific Type 2 Diabetes Therapeutics Revenue ($) by Countries (2015-2020) Table Asia-Pacific Type 2 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020) Figure Asia-Pacific Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2015 Figure Asia-Pacific Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2019 Figure China Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Japan Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure South Korea Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Australia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure India Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Southeast Asia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Middle East and Africa Type 2 Diabetes Therapeutics Revenue ($) and Growth (2015-2020) Table Middle East and Africa Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) Table Middle East and Africa Type 2 Diabetes Therapeutics Sales Market Share by Countries (2015-2020) Table Middle East and Africa Type 2 Diabetes Therapeutics Revenue ($) by Countries (2015-2020) Table Middle East and Africa Type 2 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020) Figure Middle East and Africa Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2015 Figure Middle East and Africa Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2019 Figure Saudi Arabia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure UAE Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Egypt Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Nigeria Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure South Africa Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure South America Type 2 Diabetes Therapeutics Revenue ($) and Growth (2015-2020) Table South America Type 2 Diabetes Therapeutics Sales by Countries (2015-2020) Table South America Type 2 Diabetes Therapeutics Sales Market Share by Countries (2015-2020) Table South America Type 2 Diabetes Therapeutics Revenue ($) by Countries (2015-2020) Table South America Type 2 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020) Figure South America Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2015 Figure South America Type 2 Diabetes Therapeutics Revenue Market Share by Countries in 2019 Figure Brazil Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Argentina Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Columbia Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Figure Chile Type 2 Diabetes Therapeutics Sales and Growth Rate (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales by Types (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales Share by Types (2015-2020) Table Global Type 2 Diabetes Therapeutics Revenue ($) by Types (2015-2020) Table Global Type 2 Diabetes Therapeutics Revenue Share by Types (2015-2020) Figure Global DPP-4 Inhibitors Sales and Growth Rate (2015-2020) Figure Global DPP-4 Inhibitors Price (2015-2020) Figure Global Biguanides Sales and Growth Rate (2015-2020) Figure Global Biguanides Price (2015-2020) Figure Global Insulins Sales and Growth Rate (2015-2020) Figure Global Insulins Price (2015-2020) Figure Global SGLT-2 Inhibitors Sales and Growth Rate (2015-2020) Figure Global SGLT-2 Inhibitors Price (2015-2020) Figure Global α-Glucosidase Inhibitors Sales and Growth Rate (2015-2020) Figure Global α-Glucosidase Inhibitors Price (2015-2020) Figure Global Other Sales and Growth Rate (2015-2020) Figure Global Other Price (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales by Applications (2015-2020) Table Global Type 2 Diabetes Therapeutics Sales Share by Applications (2015-2020) Figure Global Children Sales and Growth Rate (2015-2020) Figure Global Children Revenue and Growth Rate (2015-2020) Figure Global Middle-Aged Person Sales and Growth Rate (2015-2020) Figure Global Middle-Aged Person Revenue and Growth Rate (2015-2020) Figure Global Aged Sales and Growth Rate (2015-2020) Figure Global Aged Revenue and Growth Rate (2015-2020) Figure Global Type 2 Diabetes Therapeutics Sales and Growth Rate (2020-2026) Figure Global Type 2 Diabetes Therapeutics Revenue ($) and Growth Rate (2020-2026) Table Global Type 2 Diabetes Therapeutics Sales Forecast by Regions (2020-2026) Table Global Type 2 Diabetes Therapeutics Revenue Forecast by Regions (2020-2026) Figure North America Type 2 Diabetes Therapeutics Sales Forecast (2020-2026) Figure North America Type 2 Diabetes Therapeutics Revenue Forecast (2020-2026) Figure Europe Type 2 Diabetes Therapeutics Sales Forecast (2020-2026) Figure Europe Type 2 Diabetes Therapeutics Revenue Forecast (2020-2026) Figure Asia-Pacific Type 2 Diabetes Therapeutics Sales Forecast (2020-2026) Figure Asia-Pacific Type 2 Diabetes Therapeutics Revenue Forecast (2020-2026) Figure Middle East and Africa Type 2 Diabetes Therapeutics Sales Forecast (2020-2026) Figure Middle East and Africa Type 2 Diabetes Therapeutics Revenue Forecast (2020-2026) Figure South America Type 2 Diabetes Therapeutics Sales Forecast (2020-2026) Figure South America Type 2 Diabetes Therapeutics Revenue Forecast (2020-2026) Table Global Type 2 Diabetes Therapeutics Sales Forecast by Types (2020-2026) Table Global Type 2 Diabetes Therapeutics Sales Market Share Forecast by Types (2020-2026) Table Global Type 2 Diabetes Therapeutics Revenue Forecast by Types (2020-2026) Table Global Type 2 Diabetes Therapeutics Revenue Market Share Forecast by Types (2020-2026) Table Global Type 2 Diabetes Therapeutics Sales Forecast by Applications (2020-2026) Table Global Type 2 Diabetes Therapeutics Sales Market Share Forecast by Applications (2020-2026) Table Global Type 2 Diabetes Therapeutics Revenue Forecast by Applications (2020-2026) Table Global Type 2 Diabetes Therapeutics Revenue Market Share Forecast by Applications (2020-2026)